Genenta Science S.p.A (GNTA) Total Liabilities (2020 - 2025)
Genenta Science S.p.A (GNTA) posted Total Liabilities of $37.1 million for Q4 2025, up 52.15% sequentially from $24.4 million in Q2 2025, and up 134.33% YoY from $15.8 million in Q4 2024.
Genenta Science S.p.A (GNTA) Total Liabilities (2020 - 2025) Analysis & Trends
Genenta Science S.p.A has reported Total Liabilities for 6 years, with the latest figure at $37.1 million in Q4 2025.
- Quarterly Total Liabilities rose 134.33% year-over-year to $37.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $37.1 million (up 134.33% YoY) and the FY2025 annual result came in at $37.1 million, up 134.33% from the prior year.
- Total Liabilities improved to $37.1 million in Q4 2025 per GNTA's latest filing, from $24.4 million in the prior quarter.
- Over five years, Total Liabilities peaked at $45.8 million in Q4 2021 and troughed at $15.8 million in Q4 2024.
- A 5-year average of $30.2 million and a median of $29.1 million in 2023 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2024 and 2025: Total Liabilities plunged 34.12% in 2024, then soared 134.33% in 2025.
- Over 5 years, Total Liabilities stood at $45.8 million in 2021, then fell by 25.5% to $34.1 million in 2022, then fell by 29.52% to $24.0 million in 2023, then slumped by 34.12% to $15.8 million in 2024, then jumped by 134.33% to $37.1 million in 2025.
- According to Business Quant data, Total Liabilities over the past three periods registered $37.1 million, $24.4 million, and $15.8 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 10.03 Bn |
| 10 | Genenta Science S.p.A | 25.03 Mn | -34.07 Mn | - | 37.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 37.12 Mn |
| Jun 30, 2025 | 24.40 Mn |
| Dec 31, 2024 | 15.84 Mn |
| Jun 30, 2024 | 20.48 Mn |
| Dec 31, 2023 | 24.04 Mn |
| Jun 30, 2023 | 29.10 Mn |
| Dec 31, 2022 | 34.11 Mn |
| Jun 30, 2022 | 40.84 Mn |
| Dec 31, 2021 | 45.79 Mn |
| Dec 31, 2020 | 20.87 Mn |